BAKER BROS. ADVISORS LP - 26 Jun 2025 SCHEDULE 13D/A Report for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR)

Filing Manager: BAKER BROS. ADVISORS LP
Reporting Manager: Baker Bros. Advisors LP
Security: Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: KYMR
Shares outstanding: 70,174,105 shares
Disclosed Ownership: 6,666,540 shares
Ownership: 9.5%
Form type: SCHEDULE 13D/A
Filing time: 30 Jun 2025, 20:26:26 UTC
Date of event: 26 Jun 2025
Next filing: 11 Dec 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
Baker Bros. Advisors LP	9.5%	6,666,540	6,666,540	/s/ Scott L. Lessing	Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner	0001263508
Baker Bros. Advisors (GP) LLC	9.5%	6,666,540	6,666,540	/s/ Scott L. Lessing	Scott L. Lessing/ President	0001580575
Julian C. Baker	9.5%	6,666,540	6,666,540	/s/ Julian C. Baker	Julian C. Baker	0001087939
Felix J. Baker	9.5%	6,666,540	6,666,540	/s/ Felix J. Baker	Felix J. Baker	0001087940